by Alwin L | Nov 24, 2025 | Lien Resolution Processes
Legal professionals face mounting complexities in managing liens—insurance claims, medical expenses, government programs, and more—in personal injury, mass tort, and other high-stakes litigation. Lien resolution professionals have become an indispensable resource for...
by Alwin L | Nov 17, 2025 | Mass Tort Settlements
Coordinating thousands of liens in a mass tort settlement is a formidable endeavor—one that requires relentless organization, advanced technology, and deep expertise in both legal compliance and negotiation. The modern mass tort landscape includes multidistrict...
by Alwin L | Nov 10, 2025 | Mass Tort Settlements
The Depo-Provera multidistrict litigation (MDL) has quickly become one of the most closely watched pharmaceutical mass actions of the decade. Plaintiffs from across the United States have alleged that the popular contraceptive injection—manufactured by Pfizer—caused...
by Olivia Pollock | Sep 15, 2025 | Mass Tort Settlements
TDF, or tenofovir disoproxil fumarate, is a compound found in leading HIV drugs like Truvada, Viread, Atripla, Complera, and Stribild. Over the past several years, TDF litigation has taken center stage in the pharmaceutical industry, as thousands of plaintiffs have...
by Olivia Pollock | Jul 28, 2025 | MMSEA Defense Reporting
For defense firms and insurers involved in personal injury, mass tort, or workers’ compensation litigation, compliance with MMSEA Section 111 Reporting is mission-critical. The Medicare, Medicaid, and SCHIP Extension Act of 2007 (MMSEA) Section 111 imposes mandatory...
